BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1420846)

  • 1. The efficiency of a weighed log-rank test under a percent error misspecification model for the log hazard ratio.
    Zucker DM
    Biometrics; 1992 Sep; 48(3):893-9. PubMed ID: 1420846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data.
    Moodie PF; Nelson NA; Koch GG
    Stat Med; 2004 Apr; 23(7):1075-93. PubMed ID: 15057879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining stratified and unstratified log-rank tests in paired survival data.
    Oakes D; Feng C
    Stat Med; 2010 Jul; 29(16):1735-45. PubMed ID: 20572124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A linear rank test for use when the main interest is in differences in cure rates.
    Gray RJ; Tsiatis AA
    Biometrics; 1989 Sep; 45(3):899-904. PubMed ID: 2790128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint models for efficient estimation in proportional hazards regression models.
    Slasor P; Laird N
    Stat Med; 2003 Jul; 22(13):2137-48. PubMed ID: 12820279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of factorial survival experiments.
    Slud EV
    Biometrics; 1994 Mar; 50(1):25-38. PubMed ID: 8086609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interim monitoring using the adaptively weighted log-rank test in clinical trials for survival outcomes.
    Yang S
    Stat Med; 2019 Feb; 38(4):601-612. PubMed ID: 30209818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects.
    Royston P; Parmar MK
    Stat Med; 2002 Aug; 21(15):2175-97. PubMed ID: 12210632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A note on testing in Aalen's additive hazards regression models.
    Bhattacharyya M; Klein JP
    Stat Med; 2005 Jul; 24(14):2235-40. PubMed ID: 15889453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample sizes based on the log-rank statistic in complex clinical trials.
    Lakatos E
    Biometrics; 1988 Mar; 44(1):229-41. PubMed ID: 3358991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A generalized log-rank test for interval-censored failure time data via multiple imputation.
    Huang J; Lee C; Yu Q
    Stat Med; 2008 Jul; 27(17):3217-26. PubMed ID: 18254128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative tumor markers as prognostic factors of colorectal liver metastases.
    Treska V; Topolcan O; Stanislav K; Liska V; Holubec L
    Hepatogastroenterology; 2009; 56(90):317-20. PubMed ID: 19579590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reformulating the hazard ratio to enhance communication with clinical investigators.
    Moser BK; McCann MH
    Clin Trials; 2008; 5(3):248-52. PubMed ID: 18559414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some permutation tests for survival data.
    Sun Y; Sherman M
    Biometrics; 1996 Mar; 52(1):87-97. PubMed ID: 8934586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proportional hazards model taking account of long-term survivors.
    Tsodikov A
    Biometrics; 1998 Dec; 54(4):1508-16. PubMed ID: 9883549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiency of balanced treatment allocation for survival analysis.
    Kalish LA; Harrington DP
    Biometrics; 1988 Sep; 44(3):815-21. PubMed ID: 3203130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
    Kim K; Boucher H; Tsiatis AA
    Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dealing with the proportional hazards assumption when using the proportional hazards model with a single independent variable.
    Shibata A; Hamajima N; Tamakoshi A; Suzuki S; Sasaki R; Aoki K
    Jpn J Clin Oncol; 1989 Sep; 19(3):195-201. PubMed ID: 2810819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spline-based tests in survival analysis.
    Gray RJ
    Biometrics; 1994 Sep; 50(3):640-52. PubMed ID: 7981391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing for crossover of two hazard functions using Gail and Simon's method.
    Chen YH; Liu GH
    J Biopharm Stat; 2006 May; 16(3):313-26. PubMed ID: 16724487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.